Global Complex Injectable Market Outlook 2022
SKU ID : QYR-19624148 | Publishing Date : 30-Nov-2021 | No. of pages : 102
Detailed TOC of Global Complex Injectable Market Outlook 2022
1 Complex Injectable Market Overview1.1 Product Overview and Scope of Complex Injectable
1.2 Complex Injectable Segment by Type
1.2.1 Global Complex Injectable Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Bottles
1.2.3 Vials
1.2.4 Ampules
1.2.5 Cartridges
1.3 Complex Injectable Segment by Application
1.3.1 Global Complex Injectable Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals And Clinics
1.3.3 Home Care Settings
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Complex Injectable Market Size Estimates and Forecasts
1.4.1 Global Complex Injectable Revenue 2016-2027
1.4.2 Global Complex Injectable Sales 2016-2027
1.4.3 Complex Injectable Market Size by Region: 2016 Versus 2021 Versus 2027
2 Complex Injectable Market Competition by Manufacturers
2.1 Global Complex Injectable Sales Market Share by Manufacturers (2016-2021)
2.2 Global Complex Injectable Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Complex Injectable Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Complex Injectable Manufacturing Sites, Area Served, Product Type
2.5 Complex Injectable Market Competitive Situation and Trends
2.5.1 Complex Injectable Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Complex Injectable Players Market Share by Revenue
2.5.3 Global Complex Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Complex Injectable Retrospective Market Scenario by Region
3.1 Global Complex Injectable Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Complex Injectable Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Complex Injectable Market Facts & Figures by Country
3.3.1 North America Complex Injectable Sales by Country
3.3.2 North America Complex Injectable Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Complex Injectable Market Facts & Figures by Country
3.4.1 Europe Complex Injectable Sales by Country
3.4.2 Europe Complex Injectable Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Complex Injectable Market Facts & Figures by Region
3.5.1 Asia Pacific Complex Injectable Sales by Region
3.5.2 Asia Pacific Complex Injectable Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Complex Injectable Market Facts & Figures by Country
3.6.1 Latin America Complex Injectable Sales by Country
3.6.2 Latin America Complex Injectable Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Complex Injectable Market Facts & Figures by Country
3.7.1 Middle East and Africa Complex Injectable Sales by Country
3.7.2 Middle East and Africa Complex Injectable Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Complex Injectable Historic Market Analysis by Type
4.1 Global Complex Injectable Sales Market Share by Type (2016-2021)
4.2 Global Complex Injectable Revenue Market Share by Type (2016-2021)
4.3 Global Complex Injectable Price by Type (2016-2021)
5 Global Complex Injectable Historic Market Analysis by Application
5.1 Global Complex Injectable Sales Market Share by Application (2016-2021)
5.2 Global Complex Injectable Revenue Market Share by Application (2016-2021)
5.3 Global Complex Injectable Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eli Lilly Complex Injectable Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer Complex Injectable Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva Pharmaceutical Industries
6.3.1 Teva Pharmaceutical Industries Corporation Information
6.3.2 Teva Pharmaceutical Industries Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Pharmaceutical Industries Complex Injectable Product Portfolio
6.3.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.4 Hospira
6.4.1 Hospira Corporation Information
6.4.2 Hospira Description and Business Overview
6.4.3 Hospira Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hospira Complex Injectable Product Portfolio
6.4.5 Hospira Recent Developments/Updates
6.5 Hikma Pharmaceutical
6.5.1 Hikma Pharmaceutical Corporation Information
6.5.2 Hikma Pharmaceutical Description and Business Overview
6.5.3 Hikma Pharmaceutical Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hikma Pharmaceutical Complex Injectable Product Portfolio
6.5.5 Hikma Pharmaceutical Recent Developments/Updates
6.6 Johnson & Johnson Pharmaceutical
6.6.1 Johnson & Johnson Pharmaceutical Corporation Information
6.6.2 Johnson & Johnson Pharmaceutical Description and Business Overview
6.6.3 Johnson & Johnson Pharmaceutical Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Pharmaceutical Complex Injectable Product Portfolio
6.6.5 Johnson & Johnson Pharmaceutical Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novo Nordisk Complex Injectable Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Abbvie
6.8.1 Abbvie Corporation Information
6.8.2 Abbvie Description and Business Overview
6.8.3 Abbvie Complex Injectable Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Abbvie Complex Injectable Product Portfolio
6.8.5 Abbvie Recent Developments/Updates
7 Complex Injectable Manufacturing Cost Analysis
7.1 Complex Injectable Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Complex Injectable
7.4 Complex Injectable Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Complex Injectable Distributors List
8.3 Complex Injectable Customers
9 Complex Injectable Market Dynamics
9.1 Complex Injectable Industry Trends
9.2 Complex Injectable Growth Drivers
9.3 Complex Injectable Market Challenges
9.4 Complex Injectable Market Restraints
10 Global Market Forecast
10.1 Complex Injectable Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Complex Injectable by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Complex Injectable by Type (2022-2027)
10.2 Complex Injectable Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Complex Injectable by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Complex Injectable by Application (2022-2027)
10.3 Complex Injectable Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Complex Injectable by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Complex Injectable by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Complex Injectable Market Outlook 2022
List of TablesTable 1. Global Complex Injectable Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Complex Injectable Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Complex Injectable Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Complex Injectable Covered in This Study
Table 5. Global Complex Injectable Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Complex Injectable Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Complex Injectable Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Complex Injectable Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Complex Injectable Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Complex Injectable Manufacturing Sites and Area Served
Table 11. Manufacturers Complex Injectable Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Complex Injectable by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Complex Injectable as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Complex Injectable Sales by Region (2016-2021) & (K Units)
Table 16. Global Complex Injectable Sales Market Share by Region (2016-2021)
Table 17. Global Complex Injectable Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Complex Injectable Sales by Country (2016-2021) & (K Units)
Table 19. North America Complex Injectable Sales Market Share by Country (2016-2021)
Table 20. North America Complex Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Complex Injectable Revenue Market Share by Country (2016-2021)
Table 22. Europe Complex Injectable Sales by Country (2016-2021) & (K Units)
Table 23. Europe Complex Injectable Sales Market Share by Country (2016-2021)
Table 24. Europe Complex Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Complex Injectable Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Complex Injectable Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Complex Injectable Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Complex Injectable Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Complex Injectable Revenue Market Share by Region (2016-2021)
Table 30. Latin America Complex Injectable Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Complex Injectable Sales Market Share by Country (2016-2021)
Table 32. Latin America Complex Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Complex Injectable Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Complex Injectable Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Complex Injectable Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Complex Injectable Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Complex Injectable Revenue Market Share by Country (2016-2021)
Table 38. Global Complex Injectable Sales (K Units) by Type (2016-2021)
Table 39. Global Complex Injectable Sales Market Share by Type (2016-2021)
Table 40. Global Complex Injectable Revenue (Million US$) by Type (2016-2021)
Table 41. Global Complex Injectable Revenue Share by Type (2016-2021)
Table 42. Global Complex Injectable Price (USD/Unit) by Type (2016-2021)
Table 43. Global Complex Injectable Sales (K Units) by Application (2016-2021)
Table 44. Global Complex Injectable Sales Market Share by Application (2016-2021)
Table 45. Global Complex Injectable Revenue (Million US$) by Application (2016-2021)
Table 46. Global Complex Injectable Revenue Share by Application (2016-2021)
Table 47. Global Complex Injectable Price (USD/Unit) by Application (2016-2021)
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Business Overview
Table 50. Eli Lilly Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Eli Lilly Complex Injectable Product
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Pfizer Corporation Information
Table 54. Pfizer Description and Business Overview
Table 55. Pfizer Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pfizer Complex Injectable Product
Table 57. Pfizer Recent Developments/Updates
Table 58. Teva Pharmaceutical Industries Corporation Information
Table 59. Teva Pharmaceutical Industries Description and Business Overview
Table 60. Teva Pharmaceutical Industries Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Teva Pharmaceutical Industries Complex Injectable Product
Table 62. Teva Pharmaceutical Industries Recent Developments/Updates
Table 63. Hospira Corporation Information
Table 64. Hospira Description and Business Overview
Table 65. Hospira Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Hospira Complex Injectable Product
Table 67. Hospira Recent Developments/Updates
Table 68. Hikma Pharmaceutical Corporation Information
Table 69. Hikma Pharmaceutical Description and Business Overview
Table 70. Hikma Pharmaceutical Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Hikma Pharmaceutical Complex Injectable Product
Table 72. Hikma Pharmaceutical Recent Developments/Updates
Table 73. Johnson & Johnson Pharmaceutical Corporation Information
Table 74. Johnson & Johnson Pharmaceutical Description and Business Overview
Table 75. Johnson & Johnson Pharmaceutical Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Johnson & Johnson Pharmaceutical Complex Injectable Product
Table 77. Johnson & Johnson Pharmaceutical Recent Developments/Updates
Table 78. Novo Nordisk Corporation Information
Table 79. Novo Nordisk Description and Business Overview
Table 80. Novo Nordisk Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Novo Nordisk Complex Injectable Product
Table 82. Novo Nordisk Recent Developments/Updates
Table 83. Abbvie Corporation Information
Table 84. Abbvie Description and Business Overview
Table 85. Abbvie Complex Injectable Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Abbvie Complex Injectable Product
Table 87. Abbvie Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Complex Injectable Distributors List
Table 91. Complex Injectable Customers List
Table 92. Complex Injectable Market Trends
Table 93. Complex Injectable Growth Drivers
Table 94. Complex Injectable Market Challenges
Table 95. Complex Injectable Market Restraints
Table 96. Global Complex Injectable Sales Forecast by Type (2022-2027) & (K Units)
Table 97. Global Complex Injectable Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Complex Injectable Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Complex Injectable Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Complex Injectable Sales Forecast by Application (2022-2027) & (K Units)
Table 101. Global Complex Injectable Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Complex Injectable Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Complex Injectable Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Complex Injectable Sales Forecast by Region (2022-2027) & (K Units)
Table 105. Global Complex Injectable Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Complex Injectable Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Complex Injectable Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Complex Injectable
Figure 2. Global Complex Injectable Market Share by Type in 2020 & 2027
Figure 3. Bottles Product Picture
Figure 4. Vials Product Picture
Figure 5. Ampules Product Picture
Figure 6. Cartridges Product Picture
Figure 7. Global Complex Injectable Market Share by Application in 2020 & 2027
Figure 8. Hospitals And Clinics
Figure 9. Home Care Settings
Figure 10. Online Pharmacies
Figure 11. Others
Figure 12. Global Complex Injectable Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Complex Injectable Market Size 2016-2027 (US$ Million)
Figure 14. Global Complex Injectable Sales 2016-2027 (K Units)
Figure 15. Global Complex Injectable Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Complex Injectable Sales Share by Manufacturers in 2020
Figure 17. Global Complex Injectable Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Complex Injectable Players: Market Share by Revenue in 2020
Figure 19. Complex Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Complex Injectable Sales Market Share by Region (2016-2021)
Figure 21. Global Complex Injectable Sales Market Share by Region in 2020
Figure 22. Global Complex Injectable Revenue Market Share by Region (2016-2021)
Figure 23. Global Complex Injectable Revenue Market Share by Region in 2020
Figure 24. U.S. Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Complex Injectable Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Complex Injectable by Type (2016-2021)
Figure 49. Sales Market Share of Complex Injectable by Application (2016-2021)
Figure 50. Sales Market Share of Complex Injectable by Application in 2020
Figure 51. Revenue Share of Complex Injectable by Application (2016-2021)
Figure 52. Revenue Share of Complex Injectable by Application in 2020
Figure 53. Manufacturing Cost Structure of Complex Injectable
Figure 54. Manufacturing Process Analysis of Complex Injectable
Figure 55. Complex Injectable Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Keyplayers in Global Complex Injectable Market Outlook 2022
Eli LillyPfizer
Teva Pharmaceutical Industries
Hospira
Hikma Pharmaceutical
Johnson & Johnson Pharmaceutical
Novo Nordisk
Abbvie